Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Capital Expenditures (2016 - 2021)

Historic Capital Expenditures for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to $30000.0.

  • Phio Pharmaceuticals' Capital Expenditures rose 27500.0% to $30000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was $51000.0, marking a year-over-year increase of 16842.11%. This contributed to the annual value of $1000.0 for FY2024, which is 8000.0% down from last year.
  • Per Phio Pharmaceuticals' latest filing, its Capital Expenditures stood at $30000.0 for Q3 2021, which was up 27500.0% from $15000.0 recorded in Q2 2021.
  • In the past 5 years, Phio Pharmaceuticals' Capital Expenditures ranged from a high of $186000.0 in Q2 2017 and a low of -$8000.0 during Q2 2020
  • Its 5-year average for Capital Expenditures is $23333.3, with a median of $8000.0 in 2020.
  • Per our database at Business Quant, Phio Pharmaceuticals' Capital Expenditures crashed by 20000.0% in 2019 and then surged by 170000.0% in 2020.
  • Over the past 5 years, Phio Pharmaceuticals' Capital Expenditures (Quarter) stood at $15000.0 in 2017, then plummeted by 66.67% to $5000.0 in 2018, then tumbled by 200.0% to -$5000.0 in 2019, then surged by 120.0% to $1000.0 in 2020, then soared by 2900.0% to $30000.0 in 2021.
  • Its Capital Expenditures stands at $30000.0 for Q3 2021, versus $15000.0 for Q2 2021 and $6000.0 for Q1 2021.